Results for
"[search-keyword]"
Sponsor content
38 result(s) found, displaying 1 to 10
- GavretoPrescription medicine decision summaryTGA decision: Gavreto (pralsetinib) is provisionally approved to treat adults with locally advanced or metastatic rearranged during transfection fusion-positive non-small cell lung cancer.
- AusPAR: VabysmoAustralian Public Assessment Report (AusPAR)Vabysmo (faricimab) for the treatment of neovascular age-related macular degeneration and diabetic macular oedema.
- Notice for glofitamab (Roche Products Pty Limited)Designation or determinationProvisional determination
- Notice for pralsetinib (Roche Products Pty Limited)Designation or determinationProvisional determination
- Notice for pralsetinib (Roche Products Pty Limited)Designation or determinationProvisional determination
- Notice for pralsetinib (Roche Products Pty Limited)Designation or determinationProvisional determination
- AusPAR: Casirivimab/imdevimabAustralian Public Assessment Report (AusPAR)Australian Public Assessment Report for Casirivimab/imdevimab
- Notice for tocilizumab (Roche Products Pty Limited)Designation or determinationProvisional approval